Completed × Carcinoma, Squamous Cell × Cisplatin × Clear all Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
Phase 2 Completed
40 enrolled 20 charts
Pembrolizumab in Combination With CRT for LA-SCCHN
Phase 1 Completed
59 enrolled 9 charts
A Clinical Trial of Endoscopic Surgery Followed by Chemotherapy and Proton Radiation for the Treatment of Tumors in the Sinus and Nasal Passages
Phase 2 Completed
3 enrolled 4 charts
DEPEND
Phase 2 Completed
35 enrolled 14 charts
De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study
Phase 2 Completed
115 enrolled 18 charts
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
Phase 2 Completed
45 enrolled 22 charts
Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer
Phase 2 Completed
80 enrolled 25 charts
CHARIOT
Phase 1 Completed
36 enrolled 24 charts
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
Phase 2 Completed
195 enrolled 19 charts
Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
Phase 3 Completed
746 enrolled
Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and Neck
Phase 1 Completed
20 enrolled
Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx
Phase 2 Completed
60 enrolled 11 charts
INFIELD
Phase 2 Completed
72 enrolled 14 charts
The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial
Phase 2 Completed
16 enrolled
Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
Phase 2 Completed
37 enrolled 6 charts
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Phase 1 Completed
3 enrolled
CIK
Phase 2/3 Completed
96 enrolled
Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer
Phase 2 Completed
153 enrolled 18 charts
Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Phase 1 Completed
3 enrolled
Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer
Phase 1 Completed
2 enrolled
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
152 enrolled 18 charts
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Phase 4 Completed
290 enrolled
Open Label, Phase I ZD6474 Head and Neck Cancer Study
Phase 1 Completed
48 enrolled
Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck
Phase 1 Completed
12 enrolled
Multimodality Treatment for Patients With Resectable Non-Small Cell Lung Cancer (NSCLC) - BEACON Study: Bevacizumab and Chemotherapy for Operable NSCLC
Phase 2 Completed
71 enrolled 7 charts
RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer
Phase 1 Completed
18 enrolled
Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck
Phase 1 Completed
10 enrolled
Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer
Phase 3 Completed
861 enrolled
IRESSAâ„¢ (Gefitinib) With Cisplatin Plus Radiotherapy for the Treatment of Previously Untreated Unresected Late Stage III/IV Non-Metastatic Head and Neck Squamous Cell Carcinoma
Phase 2 Completed
224 enrolled 21 charts
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
Phase 1/2 Completed
30 enrolled
Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
30 enrolled
Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients
Phase 3 Completed
161 enrolled